dc.contributor.author | Taylor, JB | |
dc.contributor.author | Walland, A | |
dc.contributor.author | Lees, P | |
dc.contributor.author | Gerring, EL | |
dc.contributor.author | Maitho, TE | |
dc.contributor.author | Millar, JD | |
dc.date.accessioned | 2013-06-13T12:25:58Z | |
dc.date.available | 2013-06-13T12:25:58Z | |
dc.date.issued | 1983 | |
dc.identifier.citation | Taylor JB, Walland A, Lees P, Gerring EL, Maitho TE, Millar JD (1983). Biochemical and haematological effects of a revised dosage schedule of phenylbutazone in horses. Vet Rec. 1983 Jun 25;112(26):599-602. | en |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pubmed/6879987 | |
dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/33081 | |
dc.description.abstract | Five pairs of matched horses were used to study the biochemical and haematological effects of a revised dosage schedule of phenylbutazone. One group of five horses received a phenylbutazone paste formulation daily for 12 days and a second group of five animals received a placebo preparation for a similar time. Some statistically significant differences were recorded from pretreatment levels in both groups of horses. These changes represented instability in baseline levels and could not be ascribed to phenylbutazone administration. | en |
dc.language.iso | en | en |
dc.title | Biochemical and haematological effects of a revised dosage schedule of phenylbutazone in horses | en |
dc.type | Article | en |